Chronic myeloid leukemia (CML) is a myeloproliferative disease characterized by the presence of Philadelphia translocation t(9;22)(q34;q11), resulting in the expression of a constitutively active BCR-ABL kinase. This evidence concerns the gene ABL1 and myeloproliferative disorder.